Microbiological properties of opportunistic saccharomycetes of the genus Candida in chronic, recurrent infectious inflammatory processes (literature review)
https://doi.org/10.34215/1609-1175-2023-1-19-26
Abstract
Literature review involves a problem analysis of current scientific publications on yeast-like fungi of the genus Candida of the family Saccharomycetaceae. In 90% of cases, the etiological factor of chronic, recurrent infectious and inflammatory processes is represented by residents of oral, intestinal, urogenital and skin microbiome, opportunistic Candida albicans fungi. The paper considers the relevant medical and social problem of endogenous opportunistic infections on the example of candidiasis (candidamycosis). The review presents a conceptual analysis of changes in the microbiological properties of clinically significant candida species with ubiquitous distribution: Candida albicans, Candida tropicalis, Candida glabrata, Candida krusei, Candida parapsilosis, Candida dubliniensis, Candida auris. The authors provide a current perspective on the risk of superficial and invasive candidomycosis as an opportunistic, non-cyclic infection. Signs of the same type of pathological process develop with the participation of different species of opportunistic fungi in monoculture and associations against the background of immunodeficiency.
About the Authors
I. P. Koltsov
Far Eastern State Medical University
Russian Federation
Russian Federation
Khabarovsk
N. V. Strelnikova
Far Eastern State Medical University; Tuberculosis Hospital
Russian Federation
Russian Federation
Natalia V. Strelnikova, Cand. Sci. (Med.), Associate Professor of the Department of Microbiology, Virology and Immunology FESMU, Head of the Bacteriology Laboratory of Tuberculosis Hospital
35 Muravyovа-Amurskogo str., Khabarovsk, 680000
E. V. Vitko
Far Eastern State Medical University
Russian Federation
Russian Federation
Khabarovsk
L. G. Vitko
Postgraduate Institute for Public Health Workers
Russian Federation
Russian Federation
Khabarovsk
O. E. Savlyuk
Far Eastern State Medical University
Russian Federation
Russian Federation
Khabarovsk
References
1. Neil AR Gow, Bhawna Yadav. Microbe Profile: Candida albicans: a shape-changing, opportunistic pathogenic fungus of humans. Microbiology. 2017;(8)163:1145–7. doi: 10.1099/mic.0.000499
2. Antonova EA, Kosyakova KG. Fungi of the genus Candida – pathogens of infectious conditions. Health is the basis of human potential: problems and ways to solve them (Human Potential-2019). 2019;(1):457–8 (In Russ.).
3. Nikolaeva EN. Incidence of yeast-like fungi of the genus Candida in the oral cavity in acute respiratory disease. International Research Journal. 2013;12(5):70 (In Russ.).
4. Yelinov NP, Vasilyeva NV, Stepanova AA, Chilina GA. Candida. Candidiasis. Laboratory diagnostics. St. Petersburg: Costa, 2010 (In Russ.).
5. Sergeev AYu, Sergeev YuB. Candidiasis. Nature of infection, mechanisms of aggression and protection, laboratory diagnosis, clinic and treatment. Moscow: Triada, 2001 (In Russ.).
6. Peters BM, Palmer GE, Nash AK, Lilly EA, Fidel JrPL, Noverr MC. Fungal morphogenetic pathways are required for the hallmark inflammatory response during Candida albicans vaginitis. Infection Immunity. 2014;82(2): 532–43. doi: 10.1128/IAI.01417-13
7. Zanni PCMD, Bonfim-Mendonça PS, Negri M, Nakamura SS, Donatti L, Svidzinski TIE, Consolaro MEL. Virulence factors and genetic variability of vaginal Candida albicans isolates from HIV-infected women in the post-highly active antiretroviral era. Rev. Inst. Med. trop. Sao Paulo. 2017;59:44. doi: 10.1590/S1678-9946201759044
8. Sabino R, Veríssimo C, Pereira ÁA, Antunes F. Candida auris, an agent of hospital-associated outbreaks: which challenging issues do we need to have in mind? Microorganisms. 2020;8(2):181. doi: 10.3390/microorganisms8020181
9. Kapustina OA, Kartashova OL, Potekhina LP, Utkina TM. Biofilm formation of Candida sp. isolated from different biotopes of the human body. Problems in medical mycology. 2011;13(2):81–2 (In Russ.).
10. Shevyakov MA, Avalueva EB, Baryshnikova NV. Fungi of the genus Candida in the intestine: clinical aspects (review). Problems in medical mycology. 2007; 9(4):4–11 (In Russ.).
11. Vasilyeva NV, Kruglov AN, Stepanova AA, Chilina GA, Bosak IA, Bogomolova TS. Cytological features of yeast cells of the multi-resistant pathogen Candida auris. Problems in medical mycology. 2018;20(3):3–7 (In Russ.).
12. Volosach OV. Treatment of candidiasis: opportunities and prospects (literature review). Journal of the Grodno State Medical University. 2014;(2):19–23 (In Russ.).
13. Bogadelnikov IV, Muzhetskaya NI, Smirnov GI. Modern understanding of infectious processes. News of medicine and pharmacy. 2014;4(488):10–3 (In Russ.).
14. Bogadelnikov IV, Kruger EA, Bobrysheva AV, Muzhetskaya NI. Possible prospects for the development of modern infectiology. Сhildren infections. 2015;(14)2:69–72 (In Russ.).
15. Sztajer H, Szafranski SP, Tomasch J, Reck M, Nimtz M, Rohde M, Wagner-Döbler I. Cross-feeding and interkingdom communication in dual-species biofilms of Streptococcus mutans and Candida albicans. The ISME journal. 2014;8(11):2256–71. doi: 10.1038/ismej.2014.73
16. Kirillova VP, Tkach TM, Lyamin AV, Trunin DA, Sirazetdinova AR. Filmforming ability of Candida fungi isolated from the oral mucosa of patients with chronic myeloid leukemia. Russian Journal of Dentistry. 2015;19(5):15–8 (In Russ.).
17. Lohse MB, Gulati M, Johnson AD, Nobile CJ. Development and regulation of singleand multi-species Candida albicans biofilms. Nat Rev Microbiol. 2018;16(1):19–31. doi: 10.1038/nrmicro.2017.107
18. Tsui C, Kong EF, Jabra-Rizk MA. Pathogenesis of Candida albicans biofilm. Pathog Dis. 2016;74(4). doi: 10.1093/femspd/ftw018
19. Cavalheiro M, Teixeira MC. Candida biofilms: threats, challenges, and promising strategies. FrontMed (Lausanne). 2018;5:28. doi: 10.3389/fmed.2018.00028
20. Chebotar IV, Parshikov VV Study of the effect of antimycotic drugs on biofilms formed by fungi of the Candida genus. Obstetrics and gynecology. 2013;(5):98–102 (In Russ.).
21. Sahal G, Bilkay IS. Distribution of clinical isolates of Candida spp. and antifungal susceptibility of high biofilm-forming Candida isolates. Rev. Soc. Bras. Med. Trop. 2018;51(5):644–50. doi: 10.1590/0037-8682-0136-2018
22. Khashukoeva AZ, Afonina MS, Andreasyan GO, Myasoutova AI, Overko AV. Therapeutic approaches in the treatment of vulvovaginal candidiasis. Medical Council. 2020;(13):138–46 (In Russ.). doi: 10.21518/2079-701X-2020-13-138-146
23. Rhodes J, Fisher MC. Global epidemiology of emerging Candida auris. Current opinion in microbiology. 2019;52:84–9. doi: 10.1016/j.mib.2019.05.008
24. Popova NV, Kupert AF, Kibort RV, Platonova TA, Filatova LS. Vaginal candidiasis in gynecological patients. Acta Biomedica Scientifica. 2005;1(39):85–7 (In Russ.).
25. Ostrosky-Zeichner L, Al-Obaidi M. Invasive fungal infections in the intensive care. Unit. Infect. Dis. Clin. North Am. 2017;31(3):475–87. doi: 10.1016/j.idc.2017.05.005
26. Shagdileeva EV, Shadrivova OV, Chudinovskikh YuA, Motalkina MS, Zyuzgin IS, Bogomolova TS, Vybornova IV, Khokhlova AV, Artemyeva AS, Klimko NN. The first case of acute disseminated candidiasis caused by two pathogens Candida albicans and Candida glabrata in a patient with lymphogranulomatosis. Problems in medical mycology. 2019;(2):15–21 (In Russ.).
27. Klimko NN. Mycoses: diagnosis and treatment. A Guide for Physicians. 3rd ed. reprint. and add. Moscow: Farmtek, 2017 (In Russ.).
28. Enoktayeva OV, Nikolenko MV, Trushnikov DYu. Adaptation mechanisms of Candidа fungi (literature review). Problems in medical mycology. 2022;(3):5–6 (In Russ.).
29. Barantsevich NE, Levanova VV, Barantsevich EP. Regional features of the spread of Candida auris. Clinical Microbiology and Antimicrobial Chemotherapy. 2021;23(2):117–25 (In Russ.).
30. Ivanov AA, Kulichenko TV. Candida auris: problems of diagnosis and treatment. Current Pediatrics. 2020;19(1):20–5 (In Russ.). doi: 10.15690/vsp.v19i1.2081
31. Valyshev AV, Valysheva IV, Geide IV. Formation of biofilms by fecal strains of Enterobacteria and yeast fungi of the Candida genus. Journal of Microbiology, Epidemiology and Immunobiology. 2009;(4):44–6 (In Russ.).
32. Sergeev AYu. Immunity in candidiasis. Immunopathology, allergology, infectology. 1999;(1):81–6 (In Russ.).
33. Pokrovsky VI, Pozdeev OK. Medical Microbiology; 1998 (In Russ.).
34. Alexandrova NA, Zaslavskaya MI, Ipatova AO, Makhrova TV, Ignatova NI. Analysis of biofilm formation of Candida albicans, С. auris, C. glabrata, C. krusei. Problems in medical mycology. 2022;(3):48–50 (In Russ.).
35. Lee WG, Shin JH, Uh Y, Kang MG, Kim SH, Park KH, Jang HC. First three reported cases of nosocomial fungemia caused by Candida auris. J Clin Microbiol. 2011;49(9):3139–42. doi: 10.1128/JCM.00319-11
36. Kumar A, Sachu A, Mohan K, Vinod V, Dinesh K, Karim S. Simple low cost differentiation of Candida auris from Candida haemulonii complex using CHROMagar Candida medium supplemented with Pal’s medium. Revista Ibero americana de Micologia. 2017;34(2):109–11. doi: 10.1016/j.riam.2016.11.004
37. Cortegiani A, Misseri G, Fasciana T, Giammanco A, Giarratano A, Chowdhary A. Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris. J Intensive Care. 2018;6(69). doi: 10.1186/s40560-018-0342-4
38. Schelenz S, Hagen F, Rhodes JL, Abdolrasouli A, Chowdhary A, Hall A, Ryan L, Shackleton J, Trimlett R, Meis JF, ArmstrongJames D, Fisher MC. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control. 2016;5(35). doi: 10.1186/s13756-016-0132-5
39. Welsh RM, Bentz ML, Shams A, Houston H, Lyons A, Rose LJ, Livintseva AP. Survival, persistence, and isolation of the emerging multidrug-resistant pathogenic yeast Candida auris on a plastic health care surface. J Clin Microbiol. 2017;55(10):2996–3005. doi: 10.1128/JCM.00921-17
40. Vallabhaneni S, Kallen A, Tsay S, Chow N, Welsh R, Kerins J, Kemble SK, Pacilli M, Black SR, Landon E, Ridgway J, Palmore TN, Zelzany A, Adams EH, Quinn M, Chaturvedi S, Greenko J, Fernandez R, Southwick K, Furuya EY, Calfee DP, Hamula C, Patel G, Barrett P, Lafaro P, Berkow EL, MoultonMeissner H, Noble-Wang J, Fagan RP, Jackson BR, Lockhart SR, Litvintseva AP, Chiller TM. Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus. Morb Mortal Wkly Rep. 2016;65(44):1234–7. doi: 10.15585/mmwr.mm6544e1
41. Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009;53(1):41–4. doi: 10.1111/j.1348-0421.2008.00083
42. Morozov AM, Morozova AD, Belyak MA, Zamana YuA, Zhukov SV. Infections associated with the provision of medical care. Modern view on the problem (literature review). Journal of New Medical Technologies, electronic edition. Tula, 2022;16(4):107–16 (In Russ.).
43. Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, Colombo AL, Calvo B, Cuomo CA, Desjardins CA, Berkow EL, Castanheira M, Magobo RE, Jabeen K, Asghar RJ, Meis JF, Jackson B, Chiller T, Litvintseva AP. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis. 2017;64(2):134–40. doi: 10.1093/cid/ciw691
44. Pastukhov DM. Features of the influence of Candida spp. on oral bacteria. International Student Scientific Bulletin. 2018;(1): 8–9 (In Russ.).
45. Tulasidas S, Rao P, Bhat S, Manipura R. A study on biofilm production and antifungal drug resistance among Candida species from vulvovaginal and bloodstream infections. Infect Drug Resist. 2018;11:2443–8.
46. Baryshnikova NV, Nikolenko MV. Daily proliferative activity of Candida albicans. Problems in medical mycology. 2020;22(3):48 (In Russ.).
47. Bogadelnikov IV, Muzhetskaya NI, Kruger EA. Differential diagnosis of cyclic and non-cyclic infectious processes. News of medicine and pharmacy. 2012;4(402):16–9 (In Russ.).
48. Crawford A, Wilson D. Essential metals at the host–pathogen interface: nutritional immunity and micronutrient assimilation by human fungal pathogens. FEMS yeast research. 2015;15(7). doi: 10.1093/femsyr/fov071
49. Burova SA. Systemic and localized candidiasis in diabetic patients. RMJ. 2003;17:969 (In Russ.).
50. Hall RA, Noverr MC. Fungal interactions with the human host: exploring the spectrum of symbiosis. Current opinion in microbiology. 2017;40:58–64. doi: 10.1016/j.mib.2017.10.020
Review
For citations:
Koltsov I.P., Strelnikova N.V., Vitko E.V., Vitko L.G., Savlyuk O.E. Microbiological properties of opportunistic saccharomycetes of the genus Candida in chronic, recurrent infectious inflammatory processes (literature review). Pacific Medical Journal. 2023;(1):19-26. (In Russ.) https://doi.org/10.34215/1609-1175-2023-1-19-26
Views:
4086
Email this article 